DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @HealthcareBeat | 11 |
| @Tickeron | 10 |
| @newsfilterio | 8 |
| @mikegoodma | 7 |
| @AmericanBanking | 7 |
Recent Tweets for DRNA
 |
@mikegoodma $DRNA commercial buildout for Nedosiran launch in 2H21: 1. Bring in leadership tier (complete); 2. Beginning to com… https://t.co/5FVJtCpcy0 February 28th 2020, 2:02pm |
|
@mikegoodma $DRNA supply chain relies in part on China. So far on time but as circumstances (coronavirus) change we may see sup… https://t.co/OQSBeOMrJE February 28th 2020, 2:02pm |
|
@mikegoodma $DRNA 4Q19 call. Continue to discuss w FDA a reg path for Nedosiran in PH3. Primary endpoint for PHYOX3 is annual d… https://t.co/IFX05ZlpXJ February 28th 2020, 2:02pm |
 |
@stocknewstimes Dicerna Pharmaceuticals $DRNA Given New $29.00 Price Target at Stifel Nicolaus https://t.co/In0ZZrWMdT February 28th 2020, 12:02pm |
 |
@HealthcareBeat Dicerna Pharmaceuticals Given New $29.00 Price Target at Stifel Nicolaus $DRNA https://t.co/f78MVFOxe9 February 28th 2020, 12:02pm |
 |
@SiteFocusHQ $DRNA Earnings Intelligence Analysis of recent earnings identified Dicerna Pharmaceuticals, Inc (NASDAQ: DRNA ) bus… https://t.co/rzGwfs0Qxj February 28th 2020, 12:02pm |
 |
@SeekingAlpha $DRNA - Dicerna Pharmaceuticals' (DRNA) CEO Doug Fambrough on Q4 2019 Results - Earnings Call Transcript.… https://t.co/SgBtwpsCUl February 28th 2020, 11:02am |
 |
@WatchlistN Dicerna Pharmaceuticals $DRNA Given New $29.00 Price Target at Stifel Nicolaus https://t.co/SngFmKrMo2 February 28th 2020, 11:02am |
|
@HealthcareBeat Dicerna Pharmaceuticals Given New $29.00 Price Target at Stifel Nicolaus $DRNA https://t.co/MEanvsCdxw February 28th 2020, 11:02am |
|
@stocknewstimes Dicerna Pharmaceuticals $DRNA Given New $29.00 Price Target at Stifel Nicolaus https://t.co/2XYYaUD8Xj February 28th 2020, 11:02am |
 |
@dispatchtribune Stifel Nicolaus Raises Dicerna Pharmaceuticals $DRNA Price Target to $29.00 https://t.co/xNWiivzPB9 February 28th 2020, 11:02am |
 |
@AmericanBanking Dicerna Pharmaceuticals $DRNA Price Target Raised to $29.00 https://t.co/DfHEwGmMzN #stocks February 28th 2020, 11:02am |
|
@AmericanBanking Dicerna Pharmaceuticals Inc $DRNA Sees Significant Increase in Short Interest https://t.co/kUAm5LqKfx #stocks February 28th 2020, 6:02am |
 |
@newsfilterio Dicerna™ Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update $DRNA https://t.co/GNEBAssYv7 February 27th 2020, 11:02pm |
 |
@gcassidy718 $DRNA significant stock price movement -4.33 % change recently https://t.co/og81erSpQm February 27th 2020, 8:02pm |
 |
@Tickeron $DRNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/YRsWXOXrAM February 27th 2020, 5:02pm |
 |
@StckPro $DRNA NEW ARTICLE : Dicerna Pharmaceuticals EPS misses by $0.45, misses on revenue https://t.co/TTekrf3mG6 Get all… https://t.co/Zp0jHk9fU2 February 27th 2020, 4:02pm |
 |
@MarketCurrents $DRNA - Dicerna Pharmaceuticals EPS misses by $0.45, misses on revenue https://t.co/6kugaEiB4Z February 27th 2020, 4:02pm |
|
@mikegoodma @SptAdd Agree. My $DRNA tweets typically get 1 response. Same with $MTEM. February 27th 2020, 3:02pm |
|
@mikegoodma $DRNA at Leerink Conf – First asset from $LLY collab to enter clinic 2020; Fambrough says same timeline (2 yrs) for… https://t.co/X8er4cy8AD February 27th 2020, 1:02pm |
|
@Tickeron $DRNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/VXnXioW4S9 February 26th 2020, 5:02pm |
 |
@brockthornhill RT @mikegoodma: @RNAiAnalyst Before the Roche deal, $DRNA was set to present data from first cohort in 4Q19. Once Roche was signed, DRNA fi… February 26th 2020, 3:02pm |
|
@mikegoodma @RNAiAnalyst Before the Roche deal, $DRNA was set to present data from first cohort in 4Q19. Once Roche was signed,… https://t.co/6EXvoV7e2w February 26th 2020, 1:02pm |
|
@stocknewstimes Dicerna Pharmaceuticals Inc $DRNA Given Consensus Recommendation of “Buy” by Brokerages https://t.co/PGTGhro81L February 26th 2020, 1:02pm |
 |
@dakotafinancial Dicerna Pharmaceuticals Inc $DRNA Given Consensus Recommendation of “Buy” by Brokerages https://t.co/0jKdPYQcpZ February 26th 2020, 1:02pm |
|
@AmericanBanking Dicerna Pharmaceuticals Inc $DRNA Given Consensus Recommendation of “Buy” by Brokerages https://t.co/HStTenrnQW #stocks February 26th 2020, 1:02pm |
 |
@StockConsultant $DRNA Dicerna Pharmaceutical stock attempting to move higher off 20.39 triple support area , see… https://t.co/CAHoGZqmng February 26th 2020, 10:02am |
|
@mikegoodma $DRNA to present P1 DCR-HBVS data from all cohorts mid 2020. Deal w Roche allows DRNA to exercise option to co-fund… https://t.co/EDgRvD2vYp February 26th 2020, 9:02am |
 |
@TickerReport Dicerna Pharmaceuticals $DRNA Scheduled to Post Earnings on Thursday https://t.co/VsbA24FZfV February 26th 2020, 4:02am |
 |
@ZolmaxNews Dicerna Pharmaceuticals $DRNA Set to Announce Quarterly Earnings on Thursday https://t.co/PCjD7vm8qP February 26th 2020, 4:02am |
|
@Tickeron $DRNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/q95Te4Aa6t February 25th 2020, 6:02pm |
 |
@SptAdd Amazing strength in $DRNA past 2 days February 25th 2020, 4:02pm |
 |
@EnterpriseLeade Dicerna Pharmaceuticals $DRNA Lowered to “Hold” at BidaskClub https://t.co/0UNJvJPXLm February 25th 2020, 5:02am |
 |
@ThisLincolnian Dicerna Pharmaceuticals $DRNA Lowered to “Hold” at BidaskClub https://t.co/B9XywgG2jR February 25th 2020, 5:02am |
 |
@WeekHerald $26.40 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/uUgrnGdE4G February 24th 2020, 8:02pm |
|
@Tickeron $DRNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/8zUkRTAzMa February 24th 2020, 5:02pm |
 |
@TheExtraIncome RT @TEIStocks: $DRNA STRENGHT Earnings the 28. #TEIDRNA https://t.co/pV5JhW2tYW February 24th 2020, 3:02pm |
 |
@TEIStocks $DRNA STRENGHT Earnings the 28. #TEIDRNA https://t.co/pV5JhW2tYW February 24th 2020, 3:02pm |
 |
@TheMarketsDaily Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/GjCSSI7f8E February 24th 2020, 9:02am |
|
@ZolmaxNews Dicerna Pharmaceuticals $DRNA Downgraded by BidaskClub to Hold https://t.co/Qo2GDiE9VV February 24th 2020, 8:02am |
 |
@dailypoliticaln Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/CaWKvNXdK0 February 24th 2020, 8:02am |
 |
@Gambiste1 RT @portefeuillefun: Sold 2k $DRNA at $20.76, now 2k #vssporte shares. February 24th 2020, 5:02am |
|
@HealthcareBeat SG Americas Securities Sells 2,479 Shares of Dicerna Pharmaceuticals Inc $DRNA https://t.co/aZeXQWqMzk February 24th 2020, 3:02am |
 |
@portefeuillefun Sold 2k $DRNA at $20.76, now 2k #vssporte shares. February 24th 2020, 2:02am |
|
@HealthcareBeat Dicerna™ to Report Fourth Quarter and Full Year 2019 Financial Results on Feb. 27, 2020 $DRNA https://t.co/5qsQVNBQpp February 23rd 2020, 7:02pm |
|
@Tickeron $DRNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/F0yH4vvDC4 February 23rd 2020, 7:02pm |
|
@dispatchtribune Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by BidaskClub https://t.co/urSKILwFz1 February 23rd 2020, 11:02am |
|
@dakotafinancial Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by BidaskClub https://t.co/fLHRXdnZ1m February 23rd 2020, 11:02am |
|
@WatchlistN Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by BidaskClub https://t.co/z2sDxF1jP8 February 23rd 2020, 10:02am |
|
@HealthcareBeat Dicerna Pharmaceuticals Downgraded to Hold at BidaskClub $DRNA https://t.co/iEMebrD2ZF February 22nd 2020, 8:02pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.